Upadacitinib for moderate to severe atopic dermatitis.
Navarro-Triviño F, Alcantara-Luna S, Domínguez-Cruz J, Galán-Gutiérrez M, Ruiz-Villaverde R, Pereyra-Rodriguez JJ, Armario-Hita JC.
Navarro-Triviño F, et al.
Immunotherapy. 2023 Aug;15(11):799-808. doi: 10.2217/imt-2023-0037. Epub 2023 May 17.
Immunotherapy. 2023.
PMID: 37194577
Review.